Voir en Français

Marc-André Gagnon, Professor, Carleton University and Expert Advisor at EvidenceNetwork.ca offers a critical assessment of Quebec’s “hybrid” pharmacare system involving a public-private mix. He argues that the system achieves reasonable access to prescription drugs but that it does not achieve other key policy goals, including equity of financing and effective cost-control.

This work is licensed under a Creative Commons Attribution 4.0 International License.